Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 2.19 is 53% below its 5-year average of 4.71, near the low end of its 5-year range (2.19–7.56).
As of the fiscal period ended Tuesday, June 30, 2026. 44.28% below its 12-month average of 3.93.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 2.19.
QUICK RATIO (ACID-TEST)
2.19
QUICK RATIO (ACID-TEST) AVG TTM
3.93
QUICK RATIO (ACID-TEST) AVG 3Y
4.39
QUICK RATIO (ACID-TEST) AVG 5Y
4.71
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-44.28%
CURRENT VS 3Y AVG
-50.06%
CURRENT VS 5Y AVG
-53.43%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 870 covered companies
CURRENT VS SECTOR MEDIAN
-34.67%
vs the sector median at left
Aligos Therapeutics, Inc.
Market Cap
$33.29M
Quick Ratio (Acid-Test)
2.19
TTM Avg
3.93
3Y Avg
4.39
5Y Avg
4.71
Market Cap
$33.61M
Quick Ratio (Acid-Test)
11.47
TTM Avg
9.93
3Y Avg
10.68
5Y Avg
16.03
Market Cap
$33.63M
Quick Ratio (Acid-Test)
0.06
TTM Avg
0.11
3Y Avg
0.26
5Y Avg
0.23
Market Cap
$32.93M
Quick Ratio (Acid-Test)
1.26
TTM Avg
1.70
3Y Avg
1.87
5Y Avg
1.80
Market Cap
$32.42M
Quick Ratio (Acid-Test)
3.61
TTM Avg
1.56
3Y Avg
4.91
5Y Avg
7.24
Market Cap
$34.97M
Quick Ratio (Acid-Test)
7.07
TTM Avg
2.75
3Y Avg
16.37
5Y Avg
28.22
Market Cap
$31.52M
Quick Ratio (Acid-Test)
1.10
TTM Avg
1.38
3Y Avg
1.35
5Y Avg
1.37
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aligos Therapeutics, Inc. (ALGS) | $33.29M | 2.19 | 3.93 | 4.39 | 4.71 |
| Grace Therapeutics, Inc. (GRCE)vs › | $33.61M | 11.47 | 9.93 | 10.68 | 16.03 |
| Scilex Holding Company (SCLX)vs › | $33.63M | 0.06 | 0.11 | 0.26 | 0.23 |
| Baird Medical Investment Holdings Limited (BDMD)vs › | $32.93M | 1.26 | 1.70 | 1.87 | 1.80 |
| Nephros, Inc. (NEPH)vs › | $32.79M | 2.71 | 3.27 | 3.24 | 4.04 |
| HeartBeam, Inc. (BEAT)vs › | $32.42M | 3.61 | 1.56 | 4.91 | 7.24 |
| Elutia Inc (ELUT)vs › | $34.35M | 1.64 | 1.38 | 1.12 | 1.30 |
| BriaCell Therapeutics Corp. (BCTX)vs › | $34.97M | 7.07 | 2.75 | 16.37 | 28.22 |
| Nortech Systems Incorporated (NSYS)vs › | $31.52M | 1.10 | 1.38 | 1.35 | 1.37 |
| Accuray Incorporated (ARAY)vs › | $31.11M | 0.74 | 0.82 | 0.89 | 0.96 |
Quick Ratio
2.19
Excludes inventory
Current Ratio
2.19
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 2.19 |
| 2026-03-31 | 2.56 |
| 2025-12-31 | 3.90 |
| 2025-09-30 | 4.70 |
| 2025-06-30 | 6.31 |
| 2025-03-31 | 7.56 |
| 2024-12-31 | 2.86 |
| 2024-09-30 | 3.81 |
| 2024-06-30 | 4.23 |
| 2024-03-31 | 6.25 |
| 2023-12-31 | 5.90 |
| 2023-09-30 | 3.32 |
| 2023-06-30 | 3.46 |
| 2023-03-31 | 3.90 |
| 2022-12-31 | 4.03 |
| 2022-09-30 | 4.91 |
| 2022-06-30 | 5.30 |
| 2022-03-31 | 4.72 |
| 2021-12-31 | 5.25 |
| 2021-09-30 | 7.15 |
| 2021-06-30 | 6.53 |
| 2021-03-31 | 8.71 |
| 2020-12-31 | 8.26 |
| 2020-09-30 | 3.69 |
| 2020-06-30 | 8.61 |
| 2020-03-31 | 0.00 |
| 2019-12-31 | 8.70 |
| 2019-09-30 | 0.00 |
| 2019-06-30 | 0.00 |
| 2019-03-31 | 0.00 |
| 2018-06-30 | 0.00 |
| 2018-03-31 | 0.00 |
